Growth Metrics

Novavax (NVAX) Gains from Sales and Divestitures (2019 - 2020)

Novavax (NVAX) has 2 years of Gains from Sales and Divestitures data on record, last reported at $781812.0 in Q3 2020.

  • For Q3 2020, Gains from Sales and Divestitures rose 976.33% year-over-year to $781812.0; the TTM value through Sep 2020 reached $781812.0, up 976.33%, while the annual FY2019 figure was $72637.0, N/A changed from the prior year.
  • Gains from Sales and Divestitures reached $781812.0 in Q3 2020 per NVAX's latest filing, up from $47563.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $781812.0 in Q3 2020 and bottomed at $17563.0 in Q1 2020.